YP
EW icon

YANKCOM Partnership’s Edwards Lifesciences EW Stock Holding History

YANKCOM Partnership’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53
Closed -$4.14K – 299
2025
Q2 		$4.14K Hold
53
– – ﹤0.01% 262
2025
Q1 		$3.84K Hold
53
– – ﹤0.01% 259
2024
Q4 		$3.92K Buy
+53
New +$3.71K ﹤0.01% 239

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

YANKCOM Partnership's EW Position: Q3 2025 in Review

YANKCOM Partnership sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 53 shares — an estimated $4.14K sold.

YANKCOM Partnership first reported a position in EW in Q4 2024 and held it in 3 quarters. The position peaked at $4.14K in Q2 2025. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • YANKCOM Partnership reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • YANKCOM Partnership sold 53 Edwards Lifesciences shares in Q3 2025, an estimated $4.14K.
  • YANKCOM Partnership first reported a position in Edwards Lifesciences in Q4 2024 and held it in 3 quarters.
  • YANKCOM Partnership's Edwards Lifesciences position peaked at $4.14K in Q2 2025.
  • 1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on YANKCOM Partnership's 13F filing for Q3 2025, filed 20 Oct 2025.